Lupin gets CDSCO nod for 2nd generation antihistanine medicine

The Central Drugs Standard Control Organisation (CDSCO) has given its approval to Mumbai-based multinational pharmaceutical company Lupin Limited for Bepotastine […]

By Elets News Network

Dr. Reddy’s gets USFDA approval for anti-cancer injection

Dr. Reddy’s has received an approval from US Food and Drug Administration (USFDA) for the launch of Doxorubicin Hydrochloride Liposome […]

By Elets News Network

Dr Reddys Lab, Gland Pharma to market generic injectables globally

Dr Reddys Laboratories and US-based Gland Pharma have collaborated to market and distribute a diverse portfolio of eight injectable Abbreviated […]

By Elets News Network

IMS Health acquires baring PE funded PharmARC

US based Healthcare analytics provider – IMS Health Inc. has acquired Baring PE backed PharmARC Analytics Solutions Pvt Ltd. Financial […]

By Elets News Network

Hospital chemist shops gaining importance

An audit of medicine sales shows that the drugs are fast selling in the hospitals than in chemist shops.

By Elets News Network

Drugs : Dr Reddy

Drugs Dr Reddy’s announces the launch of Pantoprazole Sodium delayed-released tablets Dr Reddy’s Laboratories has launched Pantoprazole Sodium Delayed-Released tablets(20mg […]

By Elets News Network

launch of Pantoprazole Sodium delayed-released medicine

Dr Reddy

By Elets News Network

Lupin gets FDA nod for anti-allergic tablets

Drug firm Lupin announced it has been granted final approval by the United states Food and Drug Administration (USFDA) for antihistamine Desloratadine tablets, used for treating allergies.

By Elets News Network